Ameryka\u0144ska Agencja ds. \u017bywno\u015bci i Lek\u00f3w (FDA) zatwierdzi\u0142a Byetta (aktywny sk\u0142adnik eksenatyd) do leczenia cukrzycy typu II w 2005 roku. Miliony os\u00f3b podawanych we wstrzykni\u0119ciach przyjmowa\u0142o Byetta w celu obni\u017cenia poziomu cukru we krwi. Pomimo federalnej aprobaty, Byetta okaza\u0142a si\u0119 lekiem, kt\u00f3ry jest zar\u00f3wno wadliwy, jak i niebezpieczny. Adwokat mo\u017ce pom\u00f3c Ci z\u0142o\u017cy\u0107 wniosek o odszkodowanie, je\u015bli wzi\u0105\u0142e\u015b Byetta i ponios\u0142e\u015b w rezultacie szkod\u0119.<\/p>\n
<\/p>\n
Napoli Shkolnik, PLLC is currently investigating cases for patients who have been diagnosed pancreatic cancer and thyroid cancer\u00a0while taking or after taking Byetta. These are potentially life-threatening conditions that may have a tremendous impact on a patient and his or her family, and we are prepared to seek financial compensation that can cover medical bills, lost income and the other losses and injuries associate with these side effects. Contact our offices today, or continue reading to learn more about this type 2 diabetes medication and the side effects it may cause.<\/p>\n
One of the most recent developments in Byetta side effects involves pancreatic cancer. According to a new study by researchers at the University of California, Los Angeles (UCLA), evidence of pre-cancerous cellular changes were found in diabetic patients taking incretin mimetics. The Food and Drug Administration (FDA) released a Drug Safety Communication regarding this new study in March of 2013, stating that the agency would evaluate the findings of this study. Incretin mimetics are a class of diabetic drugs, including Byetta, Januvia, Victoza and several others.<\/p>\n
<\/p>\n
Since it was approved by the U.S. Food and Drug Administration in 2005, millions of prescriptions for Byetta (exenatide) have been dispensed across the nation. From 2005 through 2009 alone, 7 million Byetta prescriptions were dispensed. Byetta is an injectable prescription medication for the treatment of type 2 diabetes, injected twice daily within 60 minutes before the first and last meals of the day. It stimulates the production of insulin in the pancreas and causes the stomach to empty itself more slowly. Combined with diet and exercise and possibly other diabetes medications, Byetta is meant to bring blood sugar to a more optimum level.<\/p>\n
Byetta is not a cure for type 2 diabetes, a condition that has been diagnosed in millions of Americans. It is instead meant to control this type of diabetes by stimulating insulin production. It is estimated that many more Americans are at risk of developing type 2 diabetes or are unaware that they are in the early stages of the condition.<\/p>\n
With the number of patients currently suffering from type 2 diabetes, it is no wonder that so many Byetta prescriptions have been written and filled. Unfortunately, as the drug increased in popularity it became evident that patients were suffering from serious side effects.<\/p>\n
<\/p>\n
Byetta zosta\u0142a powi\u0105zana z wieloma powa\u017cnymi problemami zdrowotnymi, z kt\u00f3rych niekt\u00f3re mog\u0105 by\u0107 \u015bmiertelne, je\u015bli nie s\u0105 leczone. Obejmuj\u0105 one:<\/p>\n
W rzeczywisto\u015bci w latach 2005-2008 FDA otrzyma\u0142a 78 doniesie\u0144 o pacjentach, u kt\u00f3rych rozwin\u0119\u0142y si\u0119 problemy z nerkami<\/a> jako bezpo\u015bredni skutek przyjmowania Byetty. Spo\u015br\u00f3d nich 18 wymaga\u0142o dializy, dw\u00f3ch wymaga\u0142o przeszczepu nerki, a czterech zmar\u0142o.<\/p>\n <\/p>\n Je\u015bli uwa\u017casz, \u017ce zosta\u0142e\u015b skrzywdzony bezpo\u015brednio w wyniku za\u017cycia leku Byetta, mo\u017cesz wnie\u015b\u0107 pow\u00f3dztwo przeciwko producentowi Byetta \u2014 Amylin Pharmaceuticals \u2014 lub innej stronie w \u0142a\u0144cuchu produkcyjnym lub dystrybucyjnym. Aby dochodzi\u0107 odszkodowania w post\u0119powaniu cywilnym, b\u0119dziesz musia\u0142 udowodni\u0107 zaniedbanie producenta leku oraz to, \u017ce wadliwy lek wyrz\u0105dzi\u0142 Ci szkod\u0119. Przyk\u0142adami zaniedba\u0144 mog\u0105 by\u0107:<\/p>\n B\u0119dziesz tak\u017ce musia\u0142 udowodni\u0107, \u017ce szkody nie zosta\u0142yby poniesione, gdyby nie zabranie Byetty.<\/p>\n <\/p>\n Although Byetta is still approved for the treatment of type 2 diabetes in adults, it is possible that patients may experience serious and life-changing side effects. Some may even be at risk of losing their lives from these. Those who have suffered injury of this kind may be entitled to financial compensation for pain, suffering, medical care and lost earnings. Future medical expenses and loss of future earnings may also be covered, depending on the case.<\/p>\n Since 2000 alone, the attorneys at Napoli Shkolnik, PLLC have recovered in excess of $2 billion in settlements and awards. We are fully committed to representing the interests of the injured, helping them seek justice in the wake of the physical pain, emotional trauma and financial losses they have experienced. We go up against the most formidable opponents, negotiating fair settlements and fighting for favorable verdicts in order to help our clients begin rebuilding and moving on with their lives. We are ready to see how we can help with your Byetta lawsuit and welcome you to kontakt<\/a> a prawnik zajmuj\u0105cy si\u0119 sporami farmaceutycznymi<\/a> at our law office to discuss your rights and options. Your initial consultation is free.<\/p>\n Depending upon the state in which you live, the statute of limitations for filing a defective drug claim is usually between two and four years from the date of discovery of illness. To ensure that you file a claim within the time limits, make sure you contact the attorneys at Napoli Shkolnik, PLLC as soon as possible. We are ready to meet with you today!<\/p>","protected":false},"excerpt":{"rendered":" The U.S. Food & Drug Administration (FDA) approved Byetta (active ingredient exenatide) for the treatment of type II diabetes in 2005. Given via injection, millions of individuals have taken Byetta…<\/p>","protected":false},"featured_media":0,"menu_order":59,"template":"","practiceareas_category":[743],"class_list":["post-5670","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas\/5670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas\/5670\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/media?parent=5670"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas_category?post=5670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Czy mam pow\u00f3d do dzia\u0142ania przeciwko producentowi firmy Byetta?<\/h3>\n
\n
Podejmij dzia\u0142ania prawne, aby odzyska\u0107 odszkodowanie<\/h3>\n